Yuan Su

Yuan Su


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CPCaroline B. Plescia
Caroline B. Plescia
EDEmily A. David
Emily A. David
DPDhabaleswar Patra
Dhabaleswar Patra
Ranjan SenguptaRanjan Sengupta
Ranjan Sengupta
SASouad Amiar
Souad Amiar
RSRobert Stahelin
Robert Stahelin
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first discovered in December 2019 in Wuhan, China, and expeditiously spread across the globe causing a global pandemic. Research on SARS-CoV-2, as well as the closely related SARS-CoV-1 and MERS coronaviruses, is restricted to BSL-3 facilities. Such BSL-3 classification makes SARS-CoV-2 research inaccessible to the majority of functioning research laboratories in the United States; this becomes problematic when the collective scientific effort needs to be focused on such in the face of a pandemic. However, a minimal system capable of recapitulating different steps of the viral life cycle without using the virus' genetic material could increase accessibility. In this work, we assessed the four structural proteins from SARS-CoV-2 for their ability to form virus-like particles (VLPs) from human cells to form a competent system for BSL-2 studies of SARS-CoV-2. Herein, we provide methods and resources of producing, purifying, fluorescently and APEX2-labeling of SARS-CoV-2 VLPs for the evaluation of mechanisms of viral budding and entry as well as assessment of drug inhibitors under BSL-2 conditions. These systems should be useful to those looking to circumvent BSL-3 work with SARS-CoV-2 yet study the mechanisms by which SARS-CoV-2 enters and exits human cells.

25 March 2025 in Nature Plants
Verified
Journal Article
Closed access
PDF file
YSYuan Su
Yuan Su
YYYong Yi
Yong Yi
SGShengchao Ge
Shengchao Ge
ZWZi Wang
Zi Wang
ZWZhangyu Wei
Zhangyu Wei
YLyunfeng liu
yunfeng liu

13 February 2023 in Plant Science
Verified
Journal Article
Closed access
JLJianwu Li
Jianwu Li
YSYuan Su
Yuan Su
CSCharles A. Shapiro
Charles A. Shapiro
DSDaniel Schachtman
Daniel Schachtman
XWXuemin Wang
Xuemin Wang

1 December 2023 in The Crop Journal
Verified
Journal Article
Open access
YYYong Yi
Yong Yi
CLChan Lin
Chan Lin
XPXueyan Peng
Xueyan Peng
MZMeishan Zhang
Meishan Zhang
JWJiaming Wu
Jiaming Wu
YSYuan Su
Yuan Su

8 August 2020 in Viruses
Verified
Journal Article
Open access
PDF file
YSYuan Su
Yuan Su
RSRobert Stahelin
Robert Stahelin
Viral protein 24 (VP24) from Ebola virus (EBOV) was first recognized as a minor matrix protein that associates with cellular membranes. However, more recent studies shed light on its roles in inhibiting viral genome transcription and replication, facilitating nucleocapsid assembly and transport, and interfering with immune responses in host cells through downregulation of interferon (IFN)-activated genes. Thus, whether VP24 is a peripheral protein with lipid-binding ability for matrix layer recruitment has not been explored. Here, we examined the lipid-binding ability of VP24 with a number of lipid-binding assays. The results indicated that VP24 lacked the ability to associate with lipids tested regardless of VP24 posttranslational modifications. We further demonstrate that the presence of the EBOV major matrix protein VP40 did not promote VP24 membrane association in vitro or in cells. Further, no protein–protein interactions between VP24 and VP40 were detected by co-immunoprecipitation. Confocal imaging and cellular membrane fractionation analyses in human cells suggested VP24 did not specifically localize at the plasma membrane inner leaflet. Overall, we provide evidence that EBOV VP24 is not a lipid-binding protein and its presence in the viral matrix layer is likely not dependent on direct lipid interactions.

1 July 2006 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PMPatrick C. May
Patrick C. May
LBLeonard N. Boggs
Leonard N. Boggs
ZYZhixiang Yang
Zhixiang Yang
TLTerry D. Lindstrom
Terry D. Lindstrom
MCMichael P. Clay
Michael P. Clay
JMJames R. McCarthy
James R. McCarthy